Common Contracts
5 similar Consulting Agreement contracts by Spero Therapeutics, Inc.
CONSULTING AGREEMENTConsulting Agreement • November 14th, 2024 • Spero Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Consulting Agreement (the “Agreement”) is dated August 7, 2024, and is effective as of August 29, 2024 (the “Effective Date”) by and between Spero Therapeutics, Inc., with offices located at 675 Massachusetts Avenue, 14th Floor, Cambridge, MA 02139, together with its subsidiaries and affiliates (collectively, “Spero”) and Kamal Hamed (“Consultant”). Spero and Consultant shall be referred to individually as a “Party” and together as the “Parties”.
CONSULTING AGREEMENTConsulting Agreement • November 14th, 2024 • Spero Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Consulting Agreement (the “Agreement”) is dated August 1, 2024 and is effective as of August 5, 2024 (the “Effective Date”) by and between Spero Therapeutics, Inc., with offices located at 675 Massachusetts Avenue, 14th Floor, Cambridge, MA 02139, together with its subsidiaries and affiliates (collectively, “Spero”) and John C. Pottage, Jr., M.D. (“Consultant”). Spero and Consultant shall be referred to individually as a “Party” and together as the “Parties”.
CONSULTING AGREEMENTConsulting Agreement • March 13th, 2024 • Spero Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Consulting Agreement (the “Agreement”) is dated February 9, 2024 and is effective as of March 6, 2024 (the “Effective Date”) by and between Spero Therapeutics, Inc., with offices located at 675 Massachusetts Avenue, 14th Floor, Cambridge, MA 02139, together with its subsidiaries and affiliates (collectively, “Spero”) and Tamara Joseph (“Consultant”). Spero and Consultant shall be referred to individually as a “Party” and together as the “Parties”.
CONSULTING AGREEMENTConsulting Agreement • August 10th, 2022 • Spero Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Consulting Agreement (the “Agreement”) is dated May 3, 2022 and is effective as of July 3, 2022 (the “Effective Date”) by and between Spero Therapeutics, Inc., with offices located at 675 Massachusetts Avenue, 14th Floor, Cambridge, MA 02139, together with its subsidiaries and affiliates (collectively, “Spero”) and Cristina Larkin (“Consultant”). Spero and Consultant shall be referred to individually as a “Party” and together as the “Parties”.
CONSULTING AGREEMENTConsulting Agreement • August 10th, 2022 • Spero Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Consulting Agreement (the “Agreement”) is dated May 3, 2022 and is effective as of July 3, 2022 (the “Effective Date”) by and between Spero Therapeutics, Inc., with offices located at 675 Massachusetts Avenue, 14th Floor, Cambridge, MA 02139, together with its subsidiaries and affiliates (collectively, “Spero”) and David Melnick, MD (“Consultant”). Spero and Consultant shall be referred to individually as a “Party” and together as the “Parties”.
